Literature DB >> 6721985

Alterations in prednisolone disposition as a result of time of administration, gender and dose.

P J Meffin, P M Brooks, B C Sallustio.   

Abstract

The disposition of total and free prednisolone has been studied in four male and four female volunteers, each of whom received an intravenous dose of 0.075 mg/kg (low) and 1.5 mg/kg (high) of prednisolone at both 06.00 h and 18.00 h. For the low dose, free prednisolone clearance was 14% lower (P = 0.012) and time-averaged prednisolone free fraction was 22% higher (P less than 0.001) in the morning, there being no circadian difference in total prednisolone clearance. There was no circadian differences in prednisolone disposition at the high dose. These findings are consistent with a mechanism in which cortisol causes a simultaneous competitive inhibition of prednisolone clearance and plasma protein binding at low, but not at high prednisolone doses. Prednisolone clearance was higher in female than in male subjects, the mean increase being 18% (P = 0.022) for total prednisolone and 21% (P = 0.036) for free prednisolone. Mean total prednisolone clearance and steady-state distribution volume were two-fold higher at the high vs the low dose (P less than 0.001), but free prednisolone clearance showed a dose dependent decrease of 11% (P = 0.019). There was no change in free prednisolone steady-state distribution volume.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721985      PMCID: PMC1463403          DOI: 10.1111/j.1365-2125.1984.tb02363.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  26 in total

1.  DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS.

Authors:  T NICHOLS; C A NUGENT; F H TYLER
Journal:  J Clin Endocrinol Metab       Date:  1965-03       Impact factor: 5.958

2.  Temporal variations of antipyrine half-life in man.

Authors:  E S Vesell; C A Shively; G T Passananti
Journal:  Clin Pharmacol Ther       Date:  1977-12       Impact factor: 6.875

Review 3.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  M E Pickup
Journal:  Clin Pharmacokinet       Date:  1979 Mar-Apr       Impact factor: 6.447

4.  Dose-dependent prednisolone kinetics.

Authors:  A Tanner; F Bochner; J Caffin; J Halliday; L Powell
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

5.  Noncompartmental determination of the steady-state volume of distribution.

Authors:  L Z Benet; R L Galeazzi
Journal:  J Pharm Sci       Date:  1979-08       Impact factor: 3.534

6.  Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma.

Authors:  F J Frey; B M Frey; L Z Benet
Journal:  Clin Chem       Date:  1979-11       Impact factor: 8.327

7.  Therapeutic utilization of the diurnal variation in pituitary-adrenocortical activity.

Authors:  E J Segre; E L Klaiber
Journal:  Calif Med       Date:  1966-05

8.  Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives.

Authors:  R K Roberts; P V Desmond; G R Wilkinson; S Schenker
Journal:  Clin Pharmacol Ther       Date:  1979-06       Impact factor: 6.875

9.  Diazepam disposition determinants.

Authors:  D J Greenblatt; M D Allen; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

10.  Diurnal variation of prednisolone binding to serum corticosteroid-binding globulin in man.

Authors:  A Angeli; R Frajria; R De Paoli; D Fonzo; F Ceresa
Journal:  Clin Pharmacol Ther       Date:  1978-01       Impact factor: 6.875

View more
  18 in total

1.  Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man.

Authors:  J A Wald; R M Law; E A Ludwig; R R Sloan; E Middleton; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1992-12

Review 2.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.

Authors:  C Rollin; O Chosidow; B Diquet; C Dutreuil; S Herson; J Revuz; J C Delchier
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Alterations in prednisolone disposition as a result of oral contraceptive use and dose.

Authors:  P J Meffin; L M Wing; B C Sallustio; P M Brooks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

5.  Cortisol does not inhibit prednisolone clearance.

Authors:  P J Meffin; B C Sallustio; Y J Purdie; R A Robson; L M Wing; P M Brooks
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

6.  Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients.

Authors:  Katherine A Barraclough; Nicole M Isbel; Brett C McWhinney; Jacobus P J Ungerer; Gregory Medley; David W Johnson; Carmel M Hawley; Diana R Leary; Scott B Campbell; Christine E Staatz
Journal:  Eur J Clin Pharmacol       Date:  2011-06-09       Impact factor: 2.953

7.  Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.

Authors:  K H Lew; E A Ludwig; M A Milad; K Donovan; E Middleton; J J Ferry; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1993-10       Impact factor: 6.875

Review 8.  Gender differences in pharmacokinetics.

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 9.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

10.  Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.

Authors:  L E Fisher; E A Ludwig; J A Wald; R R Sloan; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1992-06       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.